JPRN-UMIN000005888已完成未知
Practical combination therapy of Amlodin and angiotensin II Receptor blocker(ARB); safety and efficacy in paTieNts with hypERtension Study (PARTNER Study) - PARTNER Study
Dainippon Sumitomo Pharma Co.,Ltd.0 个研究点目标入组 6,000 人开始时间: 2011年6月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Hypertensive Patients who had already received antihypertensive combination therapy with both Amlodin and ARB,and ARB-amlodipine combination agent, before the enrollment (2)Hypertensive patients who have received amlodipine preparation except Amlodin within 12 weeks of the enrollment
研究者
相似试验
已完成
不适用
Effect of combination therapy with amlodipine and atorvastatin on blood pressure varaiability, vascular function and renal function in hypertensive patients with chronic kidney diseaseHypertension with chronic kidney disease (CKD stage 1-4)JPRN-UMIN000009045Yokohama city university hospital50
尚未招募
4 期
Combination therapy with amlodipine or trichlormetiazide added irbesartan in hypertensive patients with diabetesHypertension with diabetesJPRN-UMIN000007297Control of organ function, Kanazawa University Hospital120
进行中（未招募）
不适用
Combination of antiangiogenic therapy using the mTOR-inhibitor RAD001 and low dose chemotherapy for locally advanced and/or metastatic pancreatic cancer – a dose finding studyadvanced and/or metastatic pancreatic cancerMedDRA version: 9.1Level: LLTClassification code 10033605Term: Pancreatic cancer metastaticEUCTR2006-003403-39-DEovartis Pharma GmbH
未知
4 期
A comparison of a combination drug of an angiotensin II receptor antagonist and a low-dose diuretic vs. a high-dose angiotensin II receptor antagonist in hypertensive patientsHypertensionJPRN-UMIN000001279Vascular Care Network (VCN) Kamanza study group200
未知
4 期
A comparison of a combination drug of an angiotensin II receptor antagonist and a low-dose diuretic vs combination therapy with an angiotensin II receptor antagonist and a calcium channel blocker in hypertensive patients with metabolic syndromeHypertension with metabolic syndromeJPRN-UMIN000001238Hypertension in Metabolic syndrome CHIBA (HMS-CHIBA) Study group200